>I think I am too nearsighted for the Kera product.<
Intacs are approved only for <=3 diopters and they do not correct for astigmatism. This is one of the reasons the demand for the product has been de minimus.
The two approved ICL’s are reversible — i.e. they can be removed in almost all cases without any lasting effect. This is probably their main advantage vs LASIK.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.